Insulin analogs and cancer
Today, insulin analogs are used in millions of diabetic patients. Insulin analogs have been developed to achieve more physiological insulin replacement in terms of time course of the effect. Modifications in the amino acid sequence of the insulin molecule change the pharmacokinetics and pharmacodyna...
Main Authors: | Laura eSciacca, Rosario eLe Moli, Riccardo eVigneri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00021/full |
Similar Items
-
Insulin Receptor Isoforms in Cancer
by: Veronica Vella, et al.
Published: (2018-11-01) -
The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01) -
Insulin analogues and cancer: a note of caution
by: Joseph A.M.J.L. eJanssen, et al.
Published: (2014-05-01) -
Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs
by: Jiří Jiráček, et al.
Published: (2017-07-01) -
The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
by: Veronica Vella, et al.
Published: (2018-11-01)